|
EMERGING ISSUES: Fall 2001
SOCIAL TOPICS (Archive): EMERGING ISSUES
Controversy Building on Genetically Engineered (GE) Food
Published, Fall 2001
By Steven Heim and Heidi Soumerai
SIDEBAR to Walden Social Research & Action Update in Fall 2001 issue of Values.
In recent months, controversy is building on genetically engineered (GE) food:
- The US EPA refused to grant a tolerance level for StarLink corn due to concerns that it may cause allergic reactions, despite appeals by Aventis and food manufacturers. Even trace amounts of StarLink continue to be illegal in foods for human consumption.
- New government and industry-funded studies indicate that the most popular varieties of GE corn pose “negligible” risk to monarch butterfly populations.
- The European Union (EU) proposed full mandatory labeling and traceability requirements for GE foods, including animal feeds and products derived from GE crops such as soy oil and sugar from GE sugar beets.
- An expert committee of Codex Alimentarius, an international body with broad influence for food safety and labeling, suggested developing detailed procedures for allergenicity testing.
- The Royal Society of Canada issued a report on food biotechnology that criticized the widespread use of antibiotic-resistant marker (ABR) genes to develop GE seeds, citing potential human health problems.
- The EU has proposed GE regulations to phase out all ABR genes by 2005. The EU has also argued at Codex for language to ban the use of ABR genes.
|
The information contained herein has been prepared from sources and data we believe to be reliable, but we make no guarantee as to its adequacy, accuracy, timeliness or completeness. We cannot and do not guarantee the suitability or profitability of any particular investment. No information herein is intended as an offer or solicitation of an offer to sell or buy, or as a sponsorship of any company, security, or fund. Neither Walden nor any of its contributors make any representations about the suitability of the information contained herein. Opinions expressed herein are subject to change without notice. The writings of authors do not necessarily represent the views of Walden Asset Management, its parent, or affiliated entities. There are certain risks involved with investing, including various risks depending on the type of investment vehicle being used.
© 2011 Walden Asset Management
A Division of Boston Trust & Investment Management Company
One Beacon Street | 33rd Floor | Boston, Massachusetts 02108 | 617.726.7250
|
|
|
|